Biogen Inc. buy Cantor Fitzgerald
Start price
20.02.24
/
50%
€200.60
Target price
20.02.25
€287.58
Performance (%)
-3.12%
Price
08:00
€194.35
Summary
This prediction is currently active. With a performance of -3.12%, the BUY prediction for Biogen Inc. by Cantor_Fitzgerald is down slightly. This prediction currently runs until 20.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 7.014% | 7.014% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat